AJTMH ASTMH MEMBERSHIP INFORMATION: astmh@astmh.org
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 61(6), 1999, pp. 874-878
Copyright © 1999 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Craig, S.
Right arrow Articles by Sanchez, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Craig, S.
Right arrow Articles by Sanchez, J.
Related Collections
Right arrow Ticks
American Journal of Tropical Medicine and Hygiene, Vol 61, Issue 6, 874-878
Copyright © 1999 by American Society of Tropical Medicine and Hygiene

Research Articles


An accelerated schedule for tick-borne encephalitis vaccine: the American Military experience in Bosnia

SC Craig, PR Pittman, TE Lewis, CA Rossi, EA Henchal, RA Kuschner, C Martinez, KF Kohlhase, JC Cuthie, GE Welch, and JL Sanchez

Tick-borne encephalitis (TBE) is a viral illness endemic to the Balkan region. United States military forces were deployed to Bosnia in early 1996 as part of Operation Joint Endeavor, a U.S.-led multinational peace-keeping operation. To counteract the TBE threat, an inactivated, parenteral vaccine (FSME-Immun Inject; Immuno AG, Vienna, Austria) was offered to soldiers at high risk on a volunteer basis in an accelerated, 3-dose schedule (0, 7, and 28 days). Passive adverse reaction surveillance was conducted on 3,981 vaccinated personnel. Paired sera from a randomly selected group of 1,913 deployed personnel (954 who received vaccine and 959 who were unvaccinated) were tested for antibodies to TBE by an ELISA. Three-dose recipients demonstrated an 80% seroconversion rate (4-fold or greater increase in anti-TBE titers). By comparison, the TBE infection rate in the unvaccinated cohort was found to be only 0.42% (4 of 959). Only 0.18% of vaccinees reported self-limited symptoms. An accelerated immunization schedule appears to be an acceptable option for military personnel or travelers on short-term notice to TBE-endemic areas.


This article has been cited by other articles:


Home page
Epidemiol RevHome page
J. D. Grabenstein, P. R. Pittman, J. T. Greenwood, and R. J.M. Engler
Immunization to Protect the US Armed Forces: Heritage, Current Practice, and Prospects
Epidemiol. Rev., August 1, 2006; 28(1): 3 - 26.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
Y. NIR, A. PAZ, E. SABO, and I. POTASMAN
FEAR OF INJECTIONS IN YOUNG ADULTS: PREVALENCE AND ASSOCIATIONS
Am J Trop Med Hyg, March 1, 2003; 68(3): 341 - 344.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Society of Tropical Medicine and Hygiene.